Targeting the liver circadian clock by REV-ERB-alpha activation improves liver fibrosis by circadian gating of TGF-beta signaling

被引:0
|
作者
Dachraoui, Mayssa [1 ]
Juhling, Frank [1 ]
Roehlen, Natascha [1 ]
Crouchet, Emilie [1 ]
Martin, Romain [1 ]
Brignon, Nicolas [1 ]
Mailly, Laurent [1 ]
Saviano, Antonio [1 ]
Durand, Sarah [1 ]
Schuster, Catherine [1 ]
Felli, Emanuele [2 ]
Pessaux, Patrick [2 ]
Lupberger, Joachim [1 ]
Mukherji, Atish [1 ]
Baumert, Thomas [3 ,4 ]
机构
[1] Univ Strasbourg, INSERM, Inst Rech Malad Virales & Hepat Inserm, UMR S1110, Strasbourg, France
[2] Univ Strasbourg, Inst Rech Malad Virales & Hepat Inserm, INSERM,UMR S 1110, Inst Hosp Univ,Pole Hepatodigestif,Nouvel Hop Civ, Strasbourg, France
[3] Univ Strasbourg, INSERM, Inst Rech Malad Virales & Hepat Inserm,UMR S1110, Inst Hosp Univ,Pole Hepatodigestif,Nouvel Hop Civ, Strasbourg, France
[4] Inst Univ France, Strasbourg, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OS038
引用
收藏
页码:S36 / S36
页数:1
相关论文
共 29 条
  • [21] Protective Effect of Phaleria macrocarpa Water Extract (Proliverenol) against Carbon Tetrachloride-Induced Liver Fibrosis in Rats: Role of TNF-alpha and TGF-beta 1
    Sundari, Nanik
    Soetikno, Vivian
    Louisa, Melva
    Wardhani, Bantari W.
    Tjandrawinata, Raymond R.
    JOURNAL OF TOXICOLOGY, 2018, 2018
  • [22] TGF-& BETA; SIGNALING TARGETING PEPTIDE BTI615 ATTENUATED LIVER FIBROSIS BY MODULATING FIBROTIC NICHE IN CCL4-INDUCED MOUSE-MODEL
    Jiang, Qiu
    Li, Xiaomei
    Chen, Rui
    Zhu, Zhengwen
    Yue, Jiabao
    Ding, Yi
    HEPATOLOGY, 2024, 80
  • [23] Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling
    Chen, Chaojie
    Chen, Jiajun
    Wang, Ying
    Fang, Liu
    Guo, Cuiling
    Sang, Tingting
    Peng, He
    Zhao, Qian
    Chen, Shengjia
    Lin, Xiaojian
    Wang, Xingya
    PHYTOMEDICINE, 2023, 110
  • [24] Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent
    Dattaroy, Diptadip
    Seth, Ratanesh Kumar
    Sarkar, Sutapa
    Kimono, Diana
    Albadrani, Muayad
    Chandrashekaran, Varun
    Al Hasson, Firas
    Singh, Udai P.
    Fan, Daping
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Diehl, Anna Mae
    Chatterjee, Saurabh
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 841 : 33 - 48
  • [25] 9,13-di-cis-retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90
    Imai, S
    Okuno, M
    Moriwaki, H
    Muto, Y
    Murakami, K
    Shudo, K
    Suzuki, Y
    Kojima, S
    FEBS LETTERS, 1997, 411 (01) : 102 - 106
  • [26] Retraction Note: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
    Cheng Liu
    Xia Yuan
    Le Tao
    Zhuoan Cheng
    Xiuqin Dai
    Xia Sheng
    Dongying Xue
    BMC Complementary Medicine and Therapies, 22
  • [27] RETRACTED ARTICLE: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
    Cheng Liu
    Xia Yuan
    Le Tao
    Zhuoan Cheng
    Xiuqin Dai
    Xia Sheng
    Dongying Xue
    BMC Complementary Medicine and Therapies, 15
  • [28] RETRACTED: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways (Retracted Article)
    Liu, Cheng
    Yuan, Xia
    Tao, Le
    Cheng, Zhuoan
    Dai, Xiuqin
    Sheng, Xia
    Xue, Dongying
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [29] RETRACTION: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways (Retraction of Vol 15, art no 201, 2015)
    Liu, Cheng
    Yuan, Xia
    Tao, Le
    Cheng, Zhuoan
    Dai, Xiuqin
    Sheng, Xia
    Xue, Dongying
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)